Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 263

The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.

Metabolic effects of Lactobacillus reuteri DSM 17938 in people with type 2 diabetes: Arandomized controlled trial

Mobini, Reza, Tremaroli, Valentina, Ståhlman, Marcus, Karlsson, Fredrik, Levin, Max, Ljungberg, Maria, Sohlin, Maja, Bertéus Forslund, Heléne, Perkins, Rosie, Bäckhed, Fredrik, Jansson, Per‐Anders·2017·Diabetes, Obesity and Metabolism

Abstract

Aims: To investigate the metabolic effects of 12‐week oral supplementation with L actobacillus reuteri DSM 17938 in patients with type 2 diabetes on insulin therapy. Materials and methods: In a double‐blind trial, we randomized 46 people with type 2 diabetes to placebo or a low (10 8 CFU /d) or high dose (10 10 CFU /d) of L . reuteri DSM 17938 for 12 weeks. The primary endpoint was the effect of supplementation on glycated haemoglobin ( HbA1c ). Secondary endpoints were insulin sensitivity (assessed by glucose clamp), liver fat content, body composition, body fat distribution, faecal microbiota composition and serum bile acids. Results: Supplementation with L . reuteri DSM 17938 for 12 weeks did not affect HbA1c , liver steatosis, adiposity or microbiota composition. Participants who received the highest dose of L . reuteri exhibited increases in insulin sensitivity index ( ISI ) and serum levels of the secondary bile acid deoxycholic acid ( DCA ) compared with baseline, but these differences were not significant in the between‐group analyses. Post hoc analysis showed that participants who responded with increased ISI after L . reuteri supplementation had higher microbial diversity at baseline, and increased serum levels of DCA after supplementation. In addition, increases in DCA levels correlated with improvement in insulin sensitivity in the probiotic recipients. Conclusions: Intake of L . reuteri DSM 17938 for 12 weeks did not affect HbA1c in people with type 2 diabetes on insulin therapy; however, L . reuteri improved insulin sensitivity in a subset of participants and we propose that high diversity of the gut microbiota at baseline may be important.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/dom.12861

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 38 references

Cited by

See all 263

Metadata

Authors
Mobini, R., Tremaroli, V., Ståhlman, M., Karlsson, F., Levin, M., Ljungberg, M., Sohlin, M., Bertéus Forslund, H., Perkins, R., Bäckhed, F., & Jansson, P.
Venue
Diabetes, Obesity and Metabolism
Publisher
Wiley
Published
2017-02-07
Volume
19
Issue
4
Pages
579-589
ISSN
  • 1462-8902 (ISSN-L)
  • 1463-1326
OpenAlex
W2565507590
Cited by
263
References
38
FWCI
21.94
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Metabolic effects of Lactobacillus reuteri DSM 17938 in people with type 2 diabetes: Arandomized controlled trial. https://app.cochat.ai/papers/10.1111/dom.12861
The paper
Mobini, R., Tremaroli, V., Ståhlman, M., Karlsson, F., Levin, M., Ljungberg, M., Sohlin, M., Bertéus Forslund, H., Perkins, R., Bäckhed, F., & Jansson, P. (2017). Metabolic effects of Lactobacillus reuteri DSM 17938 in people with type 2 diabetes: Arandomized controlled trial. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.12861

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.